Proficio Capital Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Proficio Capital Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-104	Closed	-$10.5K	–	1353
2017 Q4	$11K	Hold	104	–	–	﹤0.01%	784
2017 Q3	$12K	Hold	104	–	–	﹤0.01%	741
2017 Q2	$12K	Buy	104 +5	+5%	+$565	0.01%	760
2017 Q1	$10K	Buy	99 +70	+241%	+$7.75K	﹤0.01%	825
2016 Q4	$3K	Buy	+29	New	+$3.04K	﹤0.01%	865

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Proficio Capital Partners's TARO Position: Q1 2018 in Review

Proficio Capital Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 104 shares — an estimated $10.5K sold.

Proficio Capital Partners first reported a position in TARO in Q4 2016 and held it in 5 quarters. The position peaked at $12K in Q3 2017. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

Proficio Capital Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
Proficio Capital Partners sold 104 Taro Pharmaceutical Industries Ltd. shares in Q1 2018, an estimated $10.5K.
Proficio Capital Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 5 quarters.
Proficio Capital Partners's Taro Pharmaceutical Industries Ltd. position peaked at $12K in Q3 2017.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Proficio Capital Partners's 13F filing for Q1 2018, filed 14 May 2018.